Impact of perioperative vasopresin use on postoperative atrial fibrillation in cardiovascular surgery
Phase 1
- Conditions
- Coronary artery disease, aortic disease and aortic valve disease in adultCoronary Artery Disease, Aortic Diseases, Aortic Valve Disease
- Registration Number
- JPRN-jRCTs041230034
- Lead Sponsor
- Tamura Takahiro
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 184
Inclusion Criteria
Male and Female
Age 18 years old to 85 years old
weight 40kg to 120kg
Patients underwent cardiovascular surgery with cardiopulmonary bypass
Understand the research and obtain written consent
Exclusion Criteria
Chronic or paroximal atrial fibrillation
mitral valve surgery
minimally invasive cardiac surgery
non median sternotomy
hyponatremia
Chronic kidney disease on hemodialysis
Patients who is not eligible for candidate for trial
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method